Research into new treatments for conjunctival SCC is ongoing. Clinical trials are exploring novel therapies, including targeted therapies and immunotherapy, to improve outcomes for patients with advanced or recurrent disease. Patients interested in participating in clinical trials should consult with their healthcare providers to explore available options.